Futurophar SRL
1.9 FTEFuturophar reported total assets of 394,606 € at the end of the 2024 financial year (annual accounts filed with the NBB on 22 Aug 2025), with 1.9 full-time equivalent.
The score of Futurophar shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2024
Change 2021 → 2024: Equity +30 % Total assets +41 % Headcount (avg FTE) +19 %
Accounts of the company itself (not consolidated).
The full file covers 9 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Futurophar's annual accounts
| 2024 | 2023 | 2022 | 2021 | 2020 | |
|---|---|---|---|---|---|
| Net result | 24,347 € | ||||
| Equity | 263,663 € | ||||
| Cash | 60,533 € | ||||
| EBITDA | 59,823 € | ||||
| Total assets | 394,606 € |
Filed annual accounts
- Year ended 31 Dec 2024filed on 22 Aug 2025
- Year ended 31 Dec 2023filed on 26 Aug 2024
- Year ended 31 Dec 2022filed on 23 Aug 2023
- Year ended 31 Dec 2021filed on 26 Aug 2022
- Year ended 31 Dec 2020filed on 31 Aug 2021
Futurophar's financial analysis
- Solvency66.8%sector median: 44.2%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Futurophar
Futurophar's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0894.964.461
- VAT number
- BE0894964461
- Peppol
- Registered · 0208:0894964461 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 16 Jan 2008
- Registered office
- 9040 Ghent
- Size
- Micro · 1.9 FTE
- Latest accounts
- 2024 · filed on 22 Aug 2025
- Activity
- Retail sale of pharmaceutical products (NACE 47730)
Futurophar (SRL) has been based in Ghent since 2008, active in: retail sale of pharmaceutical products. For 2024, it reports a net profit of 24,347 € and equity of 263,663 €; its revenue is not published. With 1.9 full-time equivalents, it is a micro-enterprise by headcount. Its solvency stands at 66.8%, above the median of its sector (44.2%).
Guide: Reading Belgian SME accounts: the five figures that count →
Companies similar to Futurophar
Companies in the same business, of comparable size and area, outside its group.
- Berghman Business and other management consultancy activities Wervik · balance sheet 426,772 €
- CCW Consulting Business and other management consultancy activities Seraing · balance sheet 490,756 €
- Swilem Pharmaceuticals Business and other management consultancy activities Evere · balance sheet 292,979 €
- Pharmacie de Rienne Retail sale of pharmaceutical products Gembloux · balance sheet 334,259 €
- Libo Consult Retail sale of pharmaceutical products Halen · balance sheet 516,567 €
- Decapharma Retail sale of pharmaceutical products Knokke-Heist · balance sheet 291,134 €
- Nimy Phar Retail sale of pharmaceutical products Mons · balance sheet 259,917 €
- Farmacie Henri Retail sale of pharmaceutical products Edegem · balance sheet 635,645 €
Frequently asked questions about Futurophar
What is the revenue of Futurophar?
Futurophar files its accounts in a format where revenue is optional: it is not published for 2024.
What is the VAT number of Futurophar?
In Belgium, the VAT number is the company number prefixed with BE: BE0894964461 for Futurophar, if the company is VAT-registered. Its company number (CBE) is 0894.964.461.
Where is the registered office of Futurophar?
According to the CBE register, the registered office of Futurophar is in 9040 Ghent.
What is the equity of Futurophar?
At the close of the 2024 financial year, the equity of Futurophar amounts to 263,663 €, a solvency of 66.8% of total assets.
How many people work at Futurophar?
1.9 full-time equivalents on average according to the 2024 social balance sheet.
Who manages Futurophar?
The register lists 2 active mandates at Futurophar. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Futurophar
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →